Perbedaan Remala Abadi Tbk. dan Merck Tbk.: Remala Abadi Tbk. diperdagangkan di Rp2.450 (kapitalisasi pasar 3,29 T, volume 24 jam 15,47 jt), sedangkan Merck Tbk. diperdagangkan di Rp3.800 (kapitalisasi pasar 1,68 T, volume 24 jam 33,3 rb). Perbedaan utamanya: Remala Abadi Tbk. lebih besar dari sisi kapitalisasi pasar, dan Remala Abadi Tbk. lebih aktif diperdagangkan (15,47 jt vs 33,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DATA | MERK | |
|---|---|---|
Kapitalisasi Pasar | 3,29 T | 1,68 T |
Volume | 15,47 jt | 33,3 rb |
Lot | 154,74 rb | 333 |
Perputaran | 37,99 M | 126,46 jt |
Harga Rata-rata | 2.454,89 | 3.797,72 |
Nilai Transaksi | 37,99 M | 126,46 jt |
Harga Ekuilibrium Indikatif | 2.450 | 3.800 |
Volume Ekuilibrium Indikatif | 2,17 rb | 9 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Remala Abadi Tbk (the Company) was established based on Deed No.5, dated March 15, 2004 made before Notary Fajra Rizqi Nasution, SH. The company started its commercial activities since 2004.
Selengkapnya di halaman DATA →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →